PMID: 9437410Jan 23, 1998Paper

No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure

Journal of Internal Medicine
Q Y YueO Nyquist

Abstract

To determine whether furosemide treatment in congestive heart failure (CHF) patients is associated with thiamine deficiency. Patients without heart failure and without diuretic treatment were included to compare with patients with CHF belonging to New York Heart Association (NYHA) functional class II and III-IV, respectively, and receiving furosemide therapy. All patients were recruited from the emergency ward of the cardiology section. Huddinge University Hospital, where they were admitted due to CHF or acute myocardial infarction. Ninety-nine patients were included from whom a blood sample was taken, as well as routine admission blood samples for the analysis of thiamine diphosphate (TPP) concentrations. Patients taking vitamin preparations were excluded. Blood TPP concentrations were measured by high performance liquid chromatography (HPLC) and compared between the patient groups by the use of ANOVA. No significant difference was found between the groups in blood TPP concentrations. Thiamine deficiency may not be a complication of furosemide treatment in the studied Swedish patient population.

References

Dec 1, 1992·The American Journal of Medicine·W C LevyD P Fishbein
Jan 1, 1992·Age and Ageing·T KwokD R Ives
Jan 1, 1985·European Journal of Clinical Pharmacology·W Weber, H Kewitz
Apr 1, 1985·Pharmacology, Biochemistry, and Behavior·C E HallS Hungerford
Jun 5, 1982·Lancet
Jan 1, 1983·Advances in Clinical Chemistry·R E Davis, G C Icke
May 1, 1995·Journal of the American Dietetic Association·J A BradyM R Horneffer
Jan 1, 1993·European Journal of Clinical Pharmacology·C M TallaksenJ Karlsen

❮ Previous
Next ❯

Citations

Jul 5, 2006·Heart Failure Reviews·Marc L AllardMichael J Sole
Jul 3, 2013·Heart Failure Clinics·Tobias D TrippelStephan von Haehling
Mar 1, 2016·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·L M TeigenW L Miller
Jun 20, 2012·Journal of the Academy of Nutrition and Dietetics·Nicholas A McKeagPascal P McKeown
Nov 13, 2007·Journal of Cardiac Failure·Sergio da CunhaCarlos Alberto Mandarim-de-Lacerda
Sep 11, 1999·The Journal of Laboratory and Clinical Medicine·J RieckD Ezra
Oct 24, 2009·Journal of the American College of Cardiology·Victor SoukoulisMihai Gheorghiade
May 9, 2014·Heart Failure Reviews·Mavra AhmedMary Keith
Mar 7, 2014·Journal of Nutrition in Gerontology and Geriatrics·Afshin NazmiGeoffrey Maxwell Robinson
Jul 28, 2009·Journal of the American Dietetic Association·Mary E KeithMichael J Sole
Dec 27, 2007·Progress in Pediatric Cardiology·Tracie L MillerNancy Strickman-Stein
Jan 18, 2006·Journal of the American College of Cardiology·Stacy A HanninenMary E Keith
Jun 13, 2000·JPEN. Journal of Parenteral and Enteral Nutrition·R ShamirG Dinari
Apr 21, 2012·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Parastoo Azizi-NaminiMary Keith
Aug 4, 2007·Congestive Heart Failure·Domenic A Sica
Apr 18, 2002·European Journal of Heart Failure·Haralampos J MilionisMoses S Elisaf
Apr 23, 2017·Clinical Chemistry and Laboratory Medicine : CCLM·Jake T B CollieRinaldo Bellomo
Oct 24, 2001·Nutrition Reviews·T Bøhmer
Jun 22, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·B H Ali, A A Al-Qarawi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.